212 related articles for article (PubMed ID: 23096092)
1. The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis.
Xiao L; Tong M; Jin Y; Huang W; Li Z
Mol Biol Rep; 2013 Feb; 40(2):1835-41. PubMed ID: 23096092
[TBL] [Abstract][Full Text] [Related]
2. Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls.
He XF; Wei W; Li SX; Su J; Zhang Y; Ye XH; Liu Y; Wang W
Mol Biol Rep; 2012 Jun; 39(6):6811-23. PubMed ID: 22297695
[TBL] [Abstract][Full Text] [Related]
3. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
Chen Y; Yu X; Li T; Yan H; Mo Z
Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
[TBL] [Abstract][Full Text] [Related]
4. Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis.
Lee YH; Kim JH; Song GG
Rheumatol Int; 2015 Jan; 35(1):159-66. PubMed ID: 24951880
[TBL] [Abstract][Full Text] [Related]
5. The association between COMT Val158Met polymorphism and migraine risk: A meta-analysis.
Liao YJ; Jiang JR; Jin SQ
Cephalalgia; 2017 May; 37(6):592-598. PubMed ID: 27154995
[TBL] [Abstract][Full Text] [Related]
6. No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis.
Zou LW; Xu XJ; Liu T; Wang HY; Fan WJ; Wang XH; Zhang ZX; Zhai JX
Genet Test Mol Biomarkers; 2013 Jan; 17(1):78-84. PubMed ID: 23116175
[TBL] [Abstract][Full Text] [Related]
7. Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis.
Lin G; Zhao J; Wu J; Andreevich O R; Zhang WH; Zhang Y; Yu L
Genet Mol Res; 2013 Dec; 12(4):6442-53. PubMed ID: 24390993
[TBL] [Abstract][Full Text] [Related]
8. The associations between the Val158Met in the catechol-O-methyltransferase (COMT) gene and the risk of uterine leiomyoma (ULM).
Feng Y; Zhao X; Zhou C; Yang L; Liu Y; Bian C; Gou J; Lin X; Wang Z; Zhao X
Gene; 2013 Oct; 529(2):296-9. PubMed ID: 23939469
[TBL] [Abstract][Full Text] [Related]
9. Lack of associations of the COMT Val158Met polymorphism with risk of endometrial and ovarian cancer: a pooled analysis of case-control studies.
Liu JX; Luo RC; Li R; Li X; Guo YW; Ding DP; Chen YZ
Asian Pac J Cancer Prev; 2014; 15(15):6181-6. PubMed ID: 25124595
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between COMT Val158Met polymorphism and prostate cancer susceptibility.
Zhang H; Zhang Z; Wu J; Xu Y; Cheng R; Li L
Urol Int; 2013; 91(2):213-9. PubMed ID: 23257985
[TBL] [Abstract][Full Text] [Related]
11. Association of Val158Met polymorphism in COMT gene with attention-deficit hyperactive disorder: An updated meta-analysis.
Kang P; Luo L; Peng X; Wang Y
Medicine (Baltimore); 2020 Nov; 99(48):e23400. PubMed ID: 33235119
[TBL] [Abstract][Full Text] [Related]
12. Association between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk.
Tan X; Chen M
Diagn Pathol; 2014 Oct; 9():192. PubMed ID: 25280560
[TBL] [Abstract][Full Text] [Related]
13. The Association between COMT Val158Met Polymorphism and the Post-Traumatic Stress Disorder Risk: A Meta-Analysis.
Su M; Song Y
Neuropsychobiology; 2022; 81(2):156-170. PubMed ID: 34657037
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis reveals a lack of association between a common catechol-O-methyltransferase (COMT) polymorphism val¹⁵⁸met and fibromyalgia.
Zhang L; Zhu J; Chen Y; Zhao J
Int J Clin Exp Pathol; 2014; 7(12):8489-97. PubMed ID: 25674213
[TBL] [Abstract][Full Text] [Related]
15. Catechol-O-methyltransferase Val158Met polymorphism and breast cancer risk in Asian population.
Li K; Li W; Zou H
Tumour Biol; 2014 Mar; 35(3):2343-50. PubMed ID: 24146281
[TBL] [Abstract][Full Text] [Related]
16. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis.
Kumar P; Rai V
Metab Brain Dis; 2020 Feb; 35(2):241-251. PubMed ID: 31879835
[TBL] [Abstract][Full Text] [Related]
17. Association between Catechol-O-Methyltransferase Val158Met (158G/A) Polymorphism and Suicide Susceptibility: A Meta-analysis.
Sadeghiyeh T; Hosseini Biouki F; Mazaheri M; Zare-Shehneh M; Neamatzadeh H; Poursharif Z
J Res Health Sci; 2017 Jun; 17(2):e00383. PubMed ID: 28676589
[TBL] [Abstract][Full Text] [Related]
18. Association of Catechol-O-methyltransferase polymorphism Val158Met and mammographic density: A meta-analysis.
Kallionpää RA; Uusitalo E; Peltonen J
Gene; 2017 Aug; 624():34-42. PubMed ID: 28473194
[TBL] [Abstract][Full Text] [Related]
19. The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.
Suzuki M; Mamun MR; Hara K; Ozeki T; Yamada Y; Kadowaki T; Honda H; Yanagihara Y; Ito YM; Kameyama S; Ohta N; Hosoi T; Arai T; Sawabe M; Takeuchi T; Takahashi S; Kitamura T
Eur Urol; 2005 Nov; 48(5):752-9. PubMed ID: 16126332
[TBL] [Abstract][Full Text] [Related]
20. [COMT Val158Met polymorphism and schizophrenia in a series of Spanish patients].
Díez-Martín J; Hoenicka J; Martínez I; Aragüés M; Rodríguez-Jiménez R; Jiménez-Arriero MA; Ponce G; Rubio G; Palomo T;
Med Clin (Barc); 2007 Jan; 128(2):41-4. PubMed ID: 17266899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
